A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Clinical trial NCT02886715 · COMPLETED
Trial details
- NCT number
- NCT02886715
- Sponsor
- Fougera Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-21
- Primary completion
- 2017-05-31
- Enrollment
- 1110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.